Posted: December 19, 2012 - 6:45 pm ET
Officials from state pharmacy boards repeatedly told members of the Food and Drug Administration that they need clarification on the definition of a nontraditional compounding pharmacy.
The FDA held a hearing Wednesday to help establish a framework for how the federal agency and the states should regulate compounding pharmacies in the wake of the fungal meningitis outbreak that has sickened 620 and led to the deaths of another 39 people.
The outbreak has prompted questions from lawmakers and other authorities about whether the FDA or state boards of pharmacies are responsible for regulating compounding pharmacies.
The FDA held a hearing Wednesday to help establish a framework for how the federal agency and the states should regulate compounding pharmacies in the wake of the fungal meningitis outbreak that has sickened 620 and led to the deaths of another 39 people.
The outbreak has prompted questions from lawmakers and other authorities about whether the FDA or state boards of pharmacies are responsible for regulating compounding pharmacies.
Read more: FDA pressed for clarity on compounding pharmacies | Modern Healthcare http://www.modernhealthcare.com/article/20121219/NEWS/312199959#ixzz2FZ5pe1Vl
?trk=tynt
No comments:
Post a Comment